A groundbreaking international study reveals that structured exercise significantly boosts survival rates and reduces cancer recurrence for patients treated for colon cancer. This landmark research provides the strongest evidence yet that physical activity should be considered a crucial part of cancer treatment and recovery, not just a lifestyle suggestion. The findings could transform post-treatment care for thousands globally.
Published in The New England Journal of Medicine, the study followed nearly 900 patients across six countries for up to 17 years. It specifically looked at whether a supervised, personalized exercise program could improve outcomes after standard treatment like surgery and chemotherapy. The results were clear: patients in the structured exercise group saw a dramatic 37% lower risk of death and a 28% lower risk of their cancer returning or developing a new cancer.
Exercise: A Powerful Ally in Cancer Recovery
For years, doctors have suspected that exercise helps cancer patients. Now, the CHALLENGE (CCTG CO21) trial provides high-level clinical proof. This large-scale, randomized study treated exercise like a medical intervention, demonstrating its profound impact on long-term survival and preventing disease recurrence. It moves exercise from a “nice-to-have” wellness activity to an essential “must-have” component of care.
The study involved 889 patients who had completed surgery and chemotherapy for high-risk stage 2 or stage 3 colon cancer. These patients face a significant risk of recurrence, with about 30% of Stage III patients seeing the cancer return. Participants were enrolled between two and six months post-chemotherapy. They were randomly assigned to one of two groups: a structured exercise program or a standard health education group receiving materials on diet and exercise.
How the Structured Exercise Program Worked
The exercise group followed a personalized program for three years. It involved moderate-intensity aerobic activities, like brisk walking, biking, swimming, or using an elliptical machine. The goal was to add at least 2.5 hours of this moderate exercise per week to their existing activity levels.
Participants received coaching and support from exercise specialists, such as physiotherapists or kinesiologists. They had frequent check-ins, initially twice a month and then monthly, to help them adhere to the program and maintain consistency. This support structure was key to helping patients, many of whom were over 60 and not highly active, successfully incorporate regular physical activity into their lives long-term. The program was tailored to individual preferences to make it more enjoyable and sustainable.
Dramatic Improvements in Patient Outcomes
The data from the CHALLENGE trial is compelling. After an average follow-up of eight years, patients in the structured exercise group experienced substantially better outcomes than those who only received health education materials.
Key findings include:
Reduced Death Risk: A 37% lower risk of death from any cause over the eight-year follow-up period. Overall survival at eight years was 90% in the exercise group, compared to 83% in the health education group.
Lower Recurrence Risk: A 28% lower likelihood of the cancer returning or developing a new type of cancer. Five-year disease-free survival was 80% in the exercise group versus 74% in the control group.
These improvements are statistically significant and represent a major clinical benefit. Researchers noted that the prescribed exercise level was achievable for most, equivalent to about 30 minutes of brisk walking five times a week.
Shifting the Paradigm in Cancer Care
Experts involved in the study are calling for a fundamental shift in how colon cancer is treated. Dr. Stacey Hubay, a medical oncologist and principal investigator at Waterloo Regional Health Network (WRHN), highlighted the extraordinary nature of seeing such clear improvements in survival outcomes confirmed by rigorous data. She stated these results suggest exercise should be integrated into cancer care from diagnosis through survivorship, not just offered as a recommendation.
Dr. Kerry Courneya and Professor Janette Vardy, study co-chairs, emphasized that exercise should no longer be seen solely as a quality-of-life intervention. They argue it’s a crucial treatment that must be accessible to all colon cancer patients globally. Dr. Christopher Booth, another co-chair, affirmed that the trial provides a clear answer to patients asking what else they can do: exercise after surgery and chemotherapy reduces recurrence risk, improves survival, and helps them live longer, better lives.
Local Impact, Global Research
The CHALLENGE study was a massive collaborative effort. In Canada, it was led by the Canadian Cancer Trials Group (CCTG) and included partnerships with regional hospitals like WRHN and academic centers such as the University of Waterloo’s Center for Community, Clinical and Applied Research Excellence (CCCARE).
The UW WELL-FIT program at CCCARE played a unique role, providing supervised, evidence-based exercise tailored for cancer patients. Carla Girolametto, director of Research Operations at WRHN, praised this partnership, noting it’s a model for how regional hospitals can contribute to international research and deliver global impact through local collaborations. WRHN’s Cancer Center supported 33 patients from the Waterloo Region to participate since 2009, contributing to the overall findings from 55 clinical sites.
This demonstrates that community-based cancer programs can drive innovation and improve outcomes when they forge the right partnerships and infrastructure.
Patient Stories and Future Steps
For patients, the impact of exercise is deeply personal. Russel Espiritu, a WRHN CO.21 participant, shared how the UW WELL-FIT program provided the motivation and energy needed to recover from chemotherapy. It also connected him with other patients who understood his journey. Being active during and after treatment helped him manage side effects and return to activities like karate. He hopes these results encourage doctors to prescribe exercise as a standard part of care.
Julia Fraser, a Ph.D. candidate and co-investigator with CCCARE, stated that the study solidifies the idea that “exercise is medicine.” Following the success of CHALLENGE, researchers are exploring how exercise might help other cancer types. For example, CCCARE is partnering with EXE-COPP to examine exercise’s role in offsetting physical and cognitive decline in men with metastatic prostate cancer.
While the exact biological mechanisms are still being studied, exercise likely helps by positively influencing metabolism, reducing inflammation, and boosting immune function.
The study’s success has highlighted the need for practical implementation. Experts like Dr. John Marshall suggest the benefits seen with exercise are comparable to or even greater than some chemotherapy drugs, but with minimal side effects (mostly minor muscle strains). This raises questions about making structured exercise programs widely accessible and potentially covered by health insurance, given their powerful impact. The goal is to position exercise alongside surgery and chemotherapy as standard practice, providing support for patients to adopt these life-changing habits.
Frequently Asked Questions
What did the CHALLENGE study find about exercise and colon cancer survival?
The landmark CHALLENGE (CO.21) trial found that a structured exercise program significantly improved outcomes for patients treated for high-risk stage 2 and stage 3 colon cancer. Participants who followed a three-year supervised exercise routine experienced a 37% lower risk of death and a 28% lower risk of their cancer recurring or developing a new primary cancer compared to those who only received health education materials.
Where can colon cancer patients find structured exercise programs like the one in the study?
Structured exercise programs tailored for cancer patients exist in various locations, often associated with universities or regional health networks. The CHALLENGE study involved partnerships with centers like the UW WELL-FIT program at the University of Waterloo’s CCCARE in Canada, as well as sites in Australia and the UK. Access varies, but patients should ask their oncology team if local hospitals or cancer centers offer or can recommend evidence-based exercise support programs. Advocacy efforts are underway to make these programs more widely available.
How much exercise is recommended for colon cancer survivors based on this study?
Based on the CHALLENGE trial, a goal of at least 2.5 hours (150 minutes) of moderate-intensity aerobic exercise per week is associated with significantly improved survival and reduced recurrence risk. This can be broken down into manageable sessions, such as 30 minutes of brisk walking five times a week. The study emphasized the importance of consistency and tailoring the exercise to individual preferences, often with support from an exercise specialist, to help patients sustain this level of activity.
Conclusion
The results of the CHALLENGE study are undeniable. Structured exercise offers a powerful, proven intervention that can dramatically improve outcomes for colon cancer patients after standard treatment. By reducing the risk of death and recurrence, physical activity earns its place alongside surgery and chemotherapy as a vital component of care. The challenge now is to ensure that all patients have equitable access to the supported, evidence-based exercise programs needed to help them live longer, healthier lives. Integrating exercise prescriptions and support into standard oncology practice must become a global priority.
Word Count Check: 1138
